Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records. The study was presented at The Liver Meeting, hosted by the American Association for the Study of Liver Diseases.
AI finds undiagnosed liver disease in early stages
